CRISPR Calls into Question Cancer Drug Target – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
CRISPR Calls into Question Cancer Drug Target
Genetic Engineering & Biotechnology News Almost a decade ago several labs discovered that MELK is overexpressed in many cancer cell types. This prompted multiple ongoing clinical trials to test whether drugs that inhibit MELK can treat cancer in patients. Over the past few years, the study … Science self-corrects: Cancer gene does not pass reproducibility test |
